Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/24 16:39 | 5/15/24 | PHGE | Health | BioPrd | Biological Products, (No Diag | Orbimed Israel Biofund Gp Limited Partnership | L3 | T | S.d | -9 | 0.3812 | 0 | -24 | 0 | 13,774 | I | |||||||||||||||
12/1/23 16:46 | 11/29/23 | PHGE | Health | BioPrd | Biological Products, (No Diag | Oron Assaf | L3 | O | Chief Bu | S | -4 | 0.3731 | 0 | -11 | -100 | 0 | D | ||||||||||||||
11/14/22 18:37 | 10/17/22 | PHGE | Health | BioPrd | Biological Products, (No Diag | Ugwumba Chidozie | AR | H | Exit For | S.m | -27 | 0.3549 | 0 | -75 | -2 | 2,997 | I | ||||||||||||||
11/14/22 18:17 | 9/16/22 | PHGE | Health | BioPrd | Biological Products, (No Diag | Ugwumba Chidozie | AR | H | Exit For | S.m | -107 | 0.3868 | 0 | -277 | -8 | 3,072 | I | ||||||||||||||
11/14/22 17:51 | 8/10/22 | PHGE | Health | BioPrd | Biological Products, (No Diag | Ugwumba Chidozie | AR | H | Exit For | S.m | -184 | 0.6384 | 0 | -289 | -8 | 3,349 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |